ɬÀï·¬

Journal News

JBC: New insights into the molecular weapons of the plant microbiome

Sasha Mushegian
Sept. 1, 2018

Like all organisms, plants are associated with bacterial communities in which helpful and harmful bacteria compete for dominance. Among the weapons of these warring bacteria are molecular syringes that some bacteria can use to inject toxins into others. In published in the Journal of Biological Chemistry, researchers at in Canada pinpointed the identity of one such toxin used by a soil-dwelling bacterium that protects plants from disease.

The NAD-degrading enzyme Tne2 is secreted through the type VI secretion system of the plant-protective bacterium Pseudomonas protegens.Courtesy of John Whitney/McMaster University

The bacterium Pseudomonas protegens can kill soil-dwelling plant pathogens, including fungi and bacteria, that attack the roots of important crops such as cotton. P. protegens releases diverse antimicrobial compounds into the soil, but was curious specifically about the compounds that it was injecting directly into other bacteria through the type VI secretion system, or T6SS.

The T6SS “is this molecular nanomachine that injects toxic protein into other species of bacteria and kills them,” Whitney said. “Plant protective bacteria that have (T6SS) can protect plants from pathogens better relative to (bacteria) that don’t have it.”

and , undergraduate students from the working with Whitney on a co-op work-study assignment, spearheaded the discovery that the toxic protein used by P. protegens against other bacteria acts on a molecule found in nearly all living cells: nicotinamide adenine dinucleotide, or NAD+.

NAD+ is a cofactor, or “helper” molecule, in many biochemical reactions. By injecting a protein that destroys NAD+, P. protegens is able to kill other bacteria.

The team then investigated the genome sequences of hundreds of other bacteria to see how widespread the strategy of targeting NAD+ is in microbial warfare. They found that many bacteria with secretion systems carry genes similar to the one encoding the NAD-targeting toxin.

“We started to see that this isn’t just a way of killing that is enacted by plant-protective bacteria,” Whitney said. “If you look at the distribution of this (protein) among all sequenced bacteria, it appears that many different bacteria in many different environmental niches use this mode of action to outcompete other bacteria.”

The abundance of these toxins in nature raises questions: How do different bacteria in different environments evolve to resist this toxin? Are NAD-targeting toxins more effective against some bacterial species than others? Understanding the diversity of bacterial weapons is an active area of study among agricultural researchers who would like to develop better ways to fight plant diseases.

“The identification and characterization of antibacterial toxins produced by plant-protective bacteria may one day allow us to engineer these bacteria to have enhanced ability to suppress pathogens,” Whitney said.

 

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Sasha Mushegian

Sasha Mushegian is a postdoctoral fellow at Georgetown University. Follow her on Twitter.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Mapping the placenta’s hormone network
Journal News

Mapping the placenta’s hormone network

Oct. 21, 2025

Study uncovers how the placenta actively metabolizes not only glucocorticoids but also novel androgens and progesterones, reshaping our understanding of pregnancy and its complications.

Biochemists and molecular biologists sweep major 2025 honors
News

Biochemists and molecular biologists sweep major 2025 honors

Oct. 20, 2025

Recent Nobel, MacArthur and Kimberly Prize honorees highlight the power of biochemistry and molecular biology to drive discovery, including immune tolerance, vaccine design and metabolic disease, and to advance medicine and improve human health.

Spider-like proteins spin defenses to control immunity
News

Spider-like proteins spin defenses to control immunity

Oct. 17, 2025

Researchers from Utrecht University discovered two distinct binding modes of a spider-shaped immune inhibitor found in serum.

A biological camera: How AI is transforming retinal imaging
Feature

A biological camera: How AI is transforming retinal imaging

Oct. 15, 2025

AI is helping clinicians see a more detailed view into the eye, allowing them to detect diabetic retinopathy earlier and expand access through tele-ophthalmology. These advances could help millions see a clearer future.

AI in the lab: The power of smarter questions
Essay

AI in the lab: The power of smarter questions

Oct. 14, 2025

An assistant professor discusses AI's evolution from a buzzword to a trusted research partner. It helps streamline reviews, troubleshoot code, save time and spark ideas, but its success relies on combining AI with expertise and critical thinking.

Training AI to uncover novel antimicrobials
Feature

Training AI to uncover novel antimicrobials

Oct. 9, 2025

Antibiotic resistance kills millions, but César de la Fuente’s lab is fighting back. By pairing AI with human insight, researchers are uncovering hidden antimicrobial peptides across the tree of life with a 93% success rate against deadly pathogens.